Dimensional Fund Advisors
AZR icon

Dimensional Fund Advisors’s Azora Therapeutics, Inc. Common Stock AZR Stock Holding History

Dimensional Fund Advisors’s Portfolio AZR Stock Details AZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-50
Closed -$63K – 3461
2022
Q1 		$63K Hold
50
– – ﹤0.01% 3442
2021
Q4 		$85K Hold
50
– – ﹤0.01% 3452
2021
Q3 		$135K Hold
50
– – ﹤0.01% 3396
2021
Q2 		$80K Hold
50
– – ﹤0.01% 3420
2021
Q1 		$76K Buy
50
+20
+67% +$30.2K ﹤0.01% 3372
2020
Q4 		$32K Buy
+30
New +$35.4K ﹤0.01% 3334

Other funds holding AZR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Raffa Wealth Management
Raffa Wealth Management Washington, District of Columbia $793M AUM 13.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Oppenheimer & Co
Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return

Dimensional Fund Advisors's AZR Position: Q2 2022 in Review

Dimensional Fund Advisors sold out of Azora Therapeutics, Inc. Common Stock (AZR) in Q2 2022, closing a stake of 50 shares — an estimated $63K sold.

Dimensional Fund Advisors first reported a position in AZR in Q4 2020 and held it in 6 quarters. The position peaked at $135K in Q3 2021. 26 funds tracked by Wall St. Rank hold AZR as of Q2 2022.

  • Dimensional Fund Advisors reported no remaining Azora Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Dimensional Fund Advisors sold 50 Azora Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $63K.
  • Dimensional Fund Advisors first reported a position in Azora Therapeutics, Inc. Common Stock in Q4 2020 and held it in 6 quarters.
  • Dimensional Fund Advisors's Azora Therapeutics, Inc. Common Stock position peaked at $135K in Q3 2021.
  • 26 funds tracked by Wall St. Rank held Azora Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Dimensional Fund Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.